Short Interest in Sysmex Corporation ADR (OTCMKTS:SSMXY) Expands By 601.3%

Sysmex Corporation ADR (OTCMKTS:SSMXY) saw a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 277,294 shares, an increase of 601.3% from the December 15th total of 39,540 shares. Based on an average daily volume of 670,805 shares, the short-interest ratio is presently 0.4 days. Approximately 0.0% of the shares of the stock are sold short. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 670,805 shares, the short-interest ratio is presently 0.4 days.

Sysmex Price Performance

Shares of OTCMKTS:SSMXY traded up $0.09 during trading on Monday, hitting $10.19. 295,770 shares of the company were exchanged, compared to its average volume of 433,793. The company has a quick ratio of 2.49, a current ratio of 3.34 and a debt-to-equity ratio of 0.11. Sysmex has a 1-year low of $9.00 and a 1-year high of $20.31. The company has a market capitalization of $6.41 billion, a P/E ratio of 20.38 and a beta of 1.13. The business’s 50 day moving average is $9.87 and its 200-day moving average is $12.52.

Sysmex (OTCMKTS:SSMXY) last issued its quarterly earnings data on Wednesday, November 5th. The company reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $826.60 million for the quarter, compared to analyst estimates of $880.80 million. Sysmex had a return on equity of 9.86% and a net margin of 9.32%. Equities analysts forecast that Sysmex will post 0.57 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group raised Sysmex from a “hold” rating to a “buy” rating in a research note on Thursday, October 9th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy”.

About Sysmex

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.